Here is just ONE terrible example from the TPP, and yes, we know for sure [View all]

[cali]

that it's in the draft. We also know that other countries are still objecting to this. In and of itself, this should be enough to oppose Congress only being able to vote yea or nay.

This is from the leaked text of the intellectual property rights chapter. The date of the article is November, 2013.

<snip>

The United States is proposing a number of provisions designed to strengthen and extend brand-name pharmaceutical companies’ monopoly privileges. For example, several provisions would support the pharmaceutical firms’ practice of “ever-greening” in which a firm will hold a patent on drug ‘x’ in tablet form, then later obtain a patent on drug ‘x’ in a gel cap, and later still obtain another patent on the same drug in capsule form. This extends patent life on a known substance, despite no new medical efficacy; thus it delays generic competition.

<snip>

much more:

http://www.washingtonpost.com/blogs/monkey-cage/wp/2013/11/15/five-key-questions-and-answers-about-the-leaked-tpp-text/